Citation Impact
Citing Papers
Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232
1990
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans
1991
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study
1993 StandoutNobel
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice
1992 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs
1990
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour
1994 StandoutNobel
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
1994
Parkinson's Disease
2003 Standout
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232
1992 StandoutNobel
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
Abnormal Plasma Catecholamine Responses in Acromegalics
1979
Increased Dopamine Receptor Sensitivity After Estrogen Treatment Using the Rat Rotation Model
1980 Science
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice
1985
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride
1983
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Multiple receptors for dopamine
1979 StandoutNature
Effects of bromocriptine on central dopaminergic receptors
1976
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Bromocriptine
1977
Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates
1983
Dopamine receptor agonists: Intrinsic activity vs. state of receptor
1983 StandoutNobel
Multiple receptors for brain dopamine in behavior regulation: Concept of dopamine-e and dopamine-i receptors
1980
Pharmacological Properties of Presynaptic Dopamine Receptor Agonists
1985 StandoutNobel
Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations
1985 StandoutNobel
Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.
1978 StandoutNobel
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
1987 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats
1993
[3H]Dihydroergocryptine binding in rat brain
1977 StandoutNobel
Works of Allison Johnson being referenced
STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l ‐DOPA
1976